Stay in touch with us: Facebook | Twitter | LinkedIn | Newsletter
ImmuniWeb® by High-Tech Bridge


High-Tech Bridge Newsletter

Subscribe to our newsletter and receive some or all of our corporate news, invitations to security events or HTB Security Advisories – you choose what you want to receive.

XSS in OneOrZero AIMS

Advisory ID:HTB23066
Product:OneOrZero AIMS
Vendor:www.oneorzero.com ( http://www.oneorzero.com/ )
Vulnerable Versions:2.8.0 Trial build231211 and probably prior
Tested Version:2.8.0 Trial build231211
Advisory Publication:December 28, 2011 [without technical details]
Vendor Notification:December 28, 2011
Public Disclosure:January 18, 2012
Vulnerability Type:Cross-Site Scripting [CWE-79]
CVE Reference:CVE-2012-0989
Risk Level:Medium
CVSSv2 Base Score:4.3 (AV:N/AC:M/Au:N/C:N/I:P/A:N)
Discovered and Provided:High-Tech Bridge Security Research Lab
 

Advisory Details:

High-Tech Bridge SA Security Research Lab has discovered vulnerability in OneOrZero AIMS, which can be exploited to perform cross-site scripting attacks.

1) Cross-site scripting (XSS) vulnerability in OneOrZero AIMS: CVE-2012-0989
Input appended to the URL after index.php is not properly sanitised before being returned to the user.
This can be exploited to execute arbitrary HTML and script code in a user's browser session in context of an affected site
The following PoC code is available:
http://[host]/index.php/%22%3E%3Cscript%3Ealert%28document.cookie%29;%3C/script% 3E
Successful exploitation of this vulnerability requires that victim is logged-in to the vulnerable website and Apache's directive "AcceptPathInfo" is "on" or "default" (default value is "default").


ImmuniWeb® On-Demand Web Application Penetration Test


Solution:
Currently we are not aware of any vendor-supplied patches or other solutions. The vendor was contacted in accordance to our Vendor Notification Policy but we didn't get any answer or feedback.
User Comments and Opinions


Have additional information to submit?
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.